一种虚拟的方法:基于虚拟现实的治疗方法的系统审查和元分析,用于收不足
Torikul Islam1, Amit Dutta Roy2
1Department of Biomedical Engineering (BME), Khulna University of Engineering & Technology, Khulna, 9230, Bangladesh; Department of Biomedical Engineering (BME), New Jersey Institute of Technology, Newark, NJ, USA.
Journal of optometry
|March 25, 2025
概括
虚拟现实 (VR) 疗法对收性缺陷 (CI) 是一种常见的视力障碍有希望. 虽然初步发现表明有效性,但由于样本规模小和方法多样化,需要更多的研究.
科学领域:
- 眼科和视觉科学 眼科和视觉科学
- 人与计算机的交互
- 康复医学 康复医学 康复医学
背景情况:
- 收性缺陷 (CI) 是一种普遍的双眼视力障碍,影响视觉舒适度和生活质量.
- 虚拟现实 (VR) 为CI治疗提供了一种新的方法,新兴研究正在探索其有效性.
- 目前缺乏基于VR的CI治疗有效性的系统性审查和元分析.
研究的目的:
- 系统地审查和元分析基于虚拟现实治疗融合不足的有效性.
- 为临床医生,患者和研究人员提供关于CI治疗VR的基于证据的见解.
- 确定当前研究中的差距,并指导基于VR的视觉治疗的未来研究.
主要方法:
- 在Google Scholar,Scopus,PubMed和Science Direct上进行系统的文献搜索,截至2024年10月1日.
- 在选 649 个初始记录后,包括 3 个符合条件的研究;评估了质量和偏差风险.
- 进行随机效应模型元分析,以确定VR治疗前后结果的平均差异.
主要成果:
- 观察到3.38的统计学上显著的整体平均差异 (95% CI: 1.61,5.16),表明基于VR的CI治疗具有积极的影响.
- 观察到中等异质性 (I2 = 54.82%),但没有统计学意义 (Q测试p = 0.1131).
- 敏感性分析和出版偏差评估 (漏斗图,Begg,Egger测试) 显示了稳定可靠的发现.
结论:
- 基于虚拟现实的治疗证明了对收不足的积极影响.
- 目前的证据受到小样本大小和研究方法的变化所限制.
- 需要进一步进行高质量的研究,以确定关于基于VR的CI治疗有效性的最终结论.
更多相关视频
07:04Virtual Reality Tools for Assessing Unilateral Spatial Neglect: A Novel Opportunity for Data Collection
Published on: March 10, 2021
3.9K
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
3.6K
相关概念视频
01:15Data Validation
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
Key parameters for method validation include:
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...